Myoblast preparation for transplantation into injured myocardium

European Heart Journal, Supplement

Volumn 8, Issue H, 2006, Pages

  Seidel, Monika ^a   Rozwadowska, Natalia ^a   Tomczak, Kinga ^a,b   Kurpisz, Maciej ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Heart regeneration; Myoblasts; Satellite cells

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; CD45 ANTIGEN; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR PAX7; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ARTICLE; CARDIOMYOPATHY; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL SURVIVAL; CELL THERAPY; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CHROMATIN IMMUNOPRECIPITATION; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO CELL; EX VIVO STUDY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE CLUSTER; GENE EXPRESSION PROFILING; HEART MUSCLE INJURY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHARMACOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MOUSE STRAIN; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PLATING MEDIUM; PRIORITY JOURNAL; SATELLITE CELL; SKELETAL MUSCLE; WILD TYPE;

EID: 33845948714     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sul061     Document Type: Article

References (66)

1. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
2. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-394.
3. Meeson AP, Hawke TJ, Graham S, Jiang N, Elterman J, Hutcheson K, Dimaio JM, Gallardo TD, Garry DJ. Cellular and molecular regulation of skeletal muscle side population cells. Stem Cells 2004;22:1305-1320.
4. Asakura A, Seale P, Girgis-Gabardo A, Rudnicki MA. Myogenic specification of side population cells in skeletal muscle. J Cell Biol 2002;159:123-134.
5. Montanaro F, Liadaki K, Schienda J, Flint A, Gussoni E, Kunkel LM. Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res 2004;298:144-154.
6. Uezumi A, Ojima K, Fukada S, Ikemoto M, Masuda S, Miyagoe-Suzuki Y, Takeda S. Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Commun 2006;341:864-873.
7. McKinney-Freeman SL, Majka SM, Jackson KA, Norwood K, Hirschi KK, Goodell MA. Altered phenotype and reduced function of muscle-derived hematopoietic stem cells. Exp Hematol 2003;31:806-814.
8. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA. Pax7 is required for the specification of myogenic satellite cells. Cell 2000;102:777-786.
9. Tsuboi K, Kawada H, Toh E, Lee YH, Tsuma M, Nakamura Y, Sato T, Ando K, Mochida J, Kato S, Hotta T. Potential and origin of the hematopoietic population in human skeletal muscle. Leuk Res 2005;29:317-324.
10. Lee JY, Qu-Petersen Z, Cao B, Kimura S, Jankowski R, Cummins J, Usas A, Gates C, Robbins P, Wernig A, Huard J. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000;150:1085-1100.
11. Jankowski RJ, Haluszczak C, Trucco M, Huard J. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther 2001;12:619-628.
12. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A, Huard J. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002;157:851-864.
13. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 1999;96:14482-14486.
14. Sun JS, Wu SY, Lin FH. The role of muscle-derived stem cells in bone tissue engineering. Biomaterials 2005;26:3953-3960.
15. Deasy BM, Gharaibeh BM, Pollett JB, Jones MM, Lucas MA, Kanda Y, Huard J. Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell 2005;16:3323-3333.
16. Alessandri G, Pagano S, Bez A, Benetti A, Pozzi S, Iannolo G, Baronio M, Invernici G, Caruso A, Muneretto C, Bisleri G, Parati E. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 2004;364:1872-1883.
17. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961;9:493-495.
18. Schienda J, Engleka KA, Jun S, Hansen MS, Epstein JA, Tabin CJ, Kunkel LM, Kardon G. Somitic origin of limb muscle satellite and side population cells. Proc Natl Acad Sci USA 2006;103:945-950.
19. Chen JC, Goldhamer DJ. Skeletal muscle stem cells. Reprod Biol Endocrinol 2003;1:101.
20. Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, Cumano A, Partridge T, Buckingham M. Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005;309:2064-2067.
21. Dhawan J, Rando TA. Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 2005;15:666-673.
22. Beauchamp JR, Heslop L, Yu DS, Tajbakhsh S, Kelly RG, Wernig A, Buckingham ME, Partridge TA, Zammit PS. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000;151:1221-1234.
23. Garry DJ, Meeson A, Elterman J, Zhao Y, Yang P, Bassel-Duby R, Williams RS. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc Natl Acad Sci USA 2000;97:5416-5421.
24. Relaix F, Montarras D, Zaffran S, Gayraud-Morel B, Rocancourt D, Tajbakhsh S, Mansouri A, Cumano A, Buckingham M. Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J Cell Biol 2006;172:91-102.
25. Reimann J, Brimah K, Schroder R, Wernig A, Beauchamp JR, Partridge TA. Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures. Cell Tissue Res 2004;315:233-242.
26. Asakura A, Komaki M, Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001;68:45-53.
27. Shefer G, Wleklinski-Lee M, Yablonka-Reuveni Z. Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway. J Cell Sci 2004;117:5393-5404.
28. Bortoli S, Renault V, Eveno E, Auffray C, Butler-Browne G, Pietu G. Gene expression profiling of human satellite cells during muscular aging using cDNA arrays. Gene 2003;321:145-154.
29. Mouly V, Aamiri A, Bigot A, Cooper RN, Di Donna S, Furling D, Gidaro T, Jacquemin V, Mamchaoui K, Negroni E, Perie S, Renault V, Silva-Barbosa SD, Butler-Browne GS. The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol Scand 2005;184:3-15.
30. Bergstrom DA, Penn BH, Strand RL, Rudnicki MA, Topscott S. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol Cell 2002;9:587-600.
31. Delgado I, Huang X, Jones S, Zhang L, Hatcher R, Gao B, Zhang P. Dynamic gene expression during the onset of myoblast differentiation in vitro. Genomics 2003;82:109-121.
32. Moran JL, Li Y, Hill AA, Mounts WM, Miller CP. Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. Physiol Genomics 2002;10:103-111.
33. Shen X, Collier JM, Hlaing M, Zhang L, Delshad EH, Bristow J, Bernstein HS. Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn 2003;226:128-138.
34. Sterrenburg E, Turk R, 't Hoen PA, van Deutekom JC, Boer JM, van Ommen GJ, den Dunnen JT. Large-scale gene expression analysis of human skeletal myoblast differentiation. Neuromuscul Disord 2004;14:507-518.
35. Tomczak KK, Marinescu VD, Ramoni MF, Sanoudou D, Montanaro F, Han M, Kunkel LM, Kohane IS, Beggs AH. Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J 2004;18:403- 405.
36. Yun K, Wold B. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr Opin Cell Biol 1996;8:877-889.
37. Zhao P, Iezzi S, Carver E, Dressman D, Gridley T, Sartorelli V, Hoffman EP. Slug is a novel downstream target of MyoD. Temporal profiling in muscle regeration. J Biol Chem 2002;277:30091-30101.
38. Chen YW, Zhao P, Borup R, Hoffman EP. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 2000;151:1321-1336.
39. Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci USA 2002;99:15000-15005.
40. Noguchi S, Tsukahara T, Fujita M, Kurokawa R, Tachikawa M, Toda T, Tsujimoto A, Arahata K, Nishino I. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 2003;12:595- 600.
41. Grounds MD, White JD, Rosenthal N, Bogoyevitch MA. The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 2002;50:589-610.
42. Daesy BM, Jankowski RJ, Huard J. Muscle-derived stem cells: characterization and potential for cell-mediated therapy. Blood Cells Mol Dis 2001;27:924-933.
43. Ott HC, McCue J, Taylor DA. Cell based cardiovascular repair. The hurdles and the opportunities. Basic Res Cardiol 2005;100:504-517.
44. Strasser H, Berjukow S, Marksteiner R, Margreiter E, Hering S, Bartsch G, Hering S. Stem cell therapy for urinary stress incontinence. Exp Gerontol 2004;39:1259-1265.
45. Pouly J, Hagege AA, Vilquin JT, Bissery A, Rouche A, Bruneval P, Duboc D, Desnos M, Fiszman M, Fromes Y, Menasché P. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 2004;110:1626-1631.
46. Cossu G, Mavilio F. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J Clin Invest 2000;105:1669-1674.
47. Scougall KT, Shaw JA. Tetracycline-regulated secretion of human insulin in transfected primary myoblasts. Biochem Biophys Res Commun 2003;304:167-175.
48. Link D, Irintchev A, Knauf U, Wernig A, Starzinski-Powitz A. A model system for studying postnatal myogenesis with tetracycline-responsive, genetically engineered clonal myoblast in vitro and in vivo. Exp Cell Res 2001;270:138-150.
49. Orive G, De Castro M, Ponce S, Hernández RM, Gascon AR, Bosch M, Alberch J, Pedraz JL. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol Ther 2005;12:283-289.
50. Yoshioka T, Okada T, Maeda Y, Ikeda U, Shimpo M, Nomoto T, Takeuchi K, Nonaka-Sarukawa M, Ito T, Takahashi M, Matsushita T, Mizukami H, Hanazono Y, Kume A, Ookawara S, Kawano M, Ishibashi S, Shimada K, Ozawa K. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice. Gene Ther 2004;11:1772-1779.
51. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001;91:534-551.
52. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-179.
53. Hooper C. Duchenne therapy trials starting in U.S., Canada. J NIH Res 1990;2:30.
54. Law PK, Goodwin TG, Fang Q, Hall TL, Quinley T, Vastagh G, Duggirala V, Larkin C, Florendo JA, Li L, Jackson T, Yoo TJ, Chase N, Neel M, Krahn T, Holcomb R. First human myoblast transfer therapy continues to show dystrophin after 6 years. Cell Transplant 1998;6:95-100.
55. Law PK, Goodwin TG, Fang Q, Quinley T, Vastagh G, Hall T, Jackson T, Deering MB, Duggirala V, Larkin C, Florendo JA, Li LM, Yoo TJ, Chase N, Neel M, Krahn T, Holcomb RL. Human gene therapy with myoblast transfer. Transplant Proc 1998;29:2234-2237.
56. Deol JR, Gilbert R, Bourget M, Moon JS, Nalbantoglu J, Karpati G. An ideal therapeutic agent for Duchenne muscular dystrophy involving a gutted adenovirus expressing full-length utrophin. Mol Ther 2005;11:101.
57. Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, Xue T, Li RA, O' Rourke B, Marban E. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 2005;97:159-167.
58. Quenneville SP, Chapdelaine P, Rousseau J, Beaulieu J, Caron NJ, Skuk D, Mills P, Olivares EC, Calos MP, Tremblay JP. Nucleofection of muscle-derived stem cells and myoblasts with ΦC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol Ther 2004;10:679-687.
59. Baj A, Bettaccini A, Casalone R, Sala A, Cherubino P, Toniolo AQ. Culture of skeletal myoblasts from human donors aged over 40 years: dynamics of cell growth and expression of differentiation markers. J Transl Med 2005;3:21.
60. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad 1998;95:15603- 15607.
61. Musarò A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001;27:195-200.
62. Benabdallah BF, Bouchentouf M, Tremblay JP. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal. Transplantation 2005;79:1696-1702.
63. Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Ther 2002;9:642-647.
64. Deasy BM, Li Y, Huard J. Tissue engineering with muscle-derived stem cells. Curr Opin Biotechnol 2004;15:419-423.
65. Hashimoto N, Murase T, Kondo S, Okuda A, Inagawa-Ogashiwa M. Muscle reconstitution by muscle satellite cell descendants with stem cell-like properties. Development 2004;131:5481-5490.
66. Jankowski RJ, Deasy BM, Cao B, Gates C, Huard J. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci 2002;115:4361-4374.